Document is current

Any future updates will be listed below

PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan

Crossref DOI link: https://doi.org/10.1007/s10147-024-02510-6

Published Online: 2024-03-29

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark